 |
Glaxosmithkline Pharmaceuticals Ltd |
Pharmaceuticals - Multinational |
|
|
BSE Code |
 |
500660 |
|
|
|
ISIN Demat |
 |
INE159A01016 |
|
|
|
Book Value |
 |
98.8545682 |
|
|
|
Mar.Cap(Rs.Cr) |
 |
46,727.27 |
|
|
|
P/E |
 |
55.18 |
|
|
|
Face Value |
 |
10 |
|
|
|
|
|
|
|
|
|
 |
|
 |
Years | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Debt-Equity Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | Long Term Debt-Equity Ratio | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | Current Ratio | 1.47 | 1.83 | 1.89 | 1.77 | 1.59 | Fixed Assets | 5.24 | 5.23 | 5.38 | 2.84 | 3.20 | Inventory | 7.16 | 6.77 | 6.21 | 5.80 | 6.65 | Debtors | 16.44 | 16.18 | 15.29 | 18.52 | 29.28 | Interest Cover Ratio | 502.66 | 462.57 | 383.39 | 178.31 | 102.68 | PBIDTM (%) | 28.60 | 28.08 | 25.83 | 24.24 | 22.75 | PBITM (%) | 26.55 | 26.03 | 23.71 | 21.55 | 20.19 | PBDTM (%) | 28.55 | 28.02 | 25.77 | 24.12 | 22.56 | CPM (%) | 21.16 | 20.94 | 54.31 | 18.97 | 8.68 | APATM (%) | 19.11 | 18.90 | 52.19 | 16.28 | 6.11 | ROCE (%) | 44.44 | 33.60 | 32.11 | 32.10 | 28.38 | RONW (%) | 36.83 | 27.43 | 80.45 | 28.49 | 9.90 |
|
|
|
|